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underlying this.Background In lean healthy humans, perivascular adipose tissue (PVAT) exerts an anticontractile effect on adjacent small
arteries, but this is lost in obesity-associated conditions such as the metabolic syndrome and type II diabetes where
there is evidence of adipocyte inﬂammation and increased oxidative stress.Methods Segments of small subcutaneous artery and perivascular fat were harvested from severely obese individuals before
(n ¼ 20) and 6 months after bariatric surgery (n ¼ 15). Small artery contractile function was examined in vitro with
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volunteers and was restored 6 months after bariatric surgery. In vitro protocols with superoxide dismutase and
catalase rescued PVAT anticontractile function in tissue from obese individuals before surgery. The improvement in
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indexes, inﬂammatory cytokines, adipokine proﬁle, and systolic blood pressure together with increased PVAT
adiponectin and nitric oxide bioavailability and reduced macrophage inﬁltration and inﬂammation. These changes
were observed despite the patients remaining severely obese.Conclusions Bariatric surgery and its attendant improvements in weight, blood pressure, inﬂammation, and metabolism
collectively reverse the obesity-induced alteration to PVAT anticontractile function. This reversal is attributable
to reductions in local adipose inﬂammation and oxidative stress with improved adiponectin and nitric oxide
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129vessels in the body and, in addition to adipocytes, contains
inﬂammatory cells, stem cells, and microvasculature. In health,
PVAT modulates the contractile tone of adjacent small
arteries by secreting vasodilatory molecules. These adipose-
derived vasodilators act independently of the endothelium
and include adiponectin (7), NO (7), hydrogen sulﬁde (8),
and palmitic acid methyl ester (9). In 2009, we performed the
ﬁrst human small artery study of PVAT and showed that
subcutaneous gluteal PVAT from lean healthy individuals
reduced adrenergic constriction in adjacent arteries, an
“anticontractile” effect. However, in patients with metabolic
syndrome the vasodilatory effect of the PVAT was entirely
lost, due to dual processes of adipose tissue hypoxia and
inﬂammation, both of which are established sequelae of ob-
esity in fat depots (7). More recently, we have seen that
macrophage activation in adipose tissue contributes to the
attenuation in PVAT anticontractile effect (10).
Bariatric surgery has been performed for nearly 60 years
and is established as the most effective clinical intervention
to achieve both signiﬁcant and sustained weight-loss in
severely obese individuals. There are 3 types of bariatric
surgical procedures: restrictive, malabsorptive, and combined
operations (11). Gastric bypass surgery is a combination of
restriction and malabsorption and has been shown to achieve
a signiﬁcantly higher degree of weight loss than restrictive
bariatric surgery (12).
Bariatric surgery also dramatically improves cardiovascular
risk proﬁles in obese patients and reduces overall mortality
(13,14). The mechanisms that underlie these cardiovascular
improvements remain unclear, however. In the present study
we investigated the effects of bariatric surgery achieved by
the gastric bypass method on the vasodilatory properties of
PVAT. We report amelioration of inﬂammation in PVAT
with complete restoration of anticontractile activity as
a consequence of improved adiponectin and NO bioavail-
ability, despite persisting obesity.Methods
Study population. Patients with severe obesity (body mass
index [BMI] >35 kg/m2) who were awaiting gastric bypass
surgery (n ¼ 15) and lean healthy volunteers (n ¼ 7) were
recruited after full informed written consent in accord with
local research ethics committee approval. All participants
provided a fasting venous blood sample for the measurement
of inﬂammatory markers and adipokines.
The study participants also provided gluteal subcuta-
neous fat samples (1.5  1.5  1.5 cm) by undergoing
a surgical biopsy under local anesthesia (7). The sample
was immediately processed in 3 sections. One part was stored
for immunohistology, the second was snap-frozen for esti-
mation of NO levels, and the remainder was used to harvest
small subcutaneous arteries with micro-dissection.
Blood pressure was recorded as a mean of 3 recordings
measured with a semi-automated machine (OMRON705CP, White Medical, Clifton-
Upon-Dunsmore, United King-
dom), whereas the participants
were seated at rest for 15 min.
Further measurements includ-
ing BMI and waist circumference
were also recorded.
The obese patients were invi-
ted to return for a follow-up as-
sessment, including a biopsy, 6
months after bariatric surgery.
Biochemical analyses. High-se-
nsitivity C-reactive protein (hs-
CRP) was measured in serum by an in-house, antibody
sandwich enzyme-linked immunoadsorbent assay technique
with anti-human CRP antibodies, calibrators, and controls
from Abcam (Cambridge, United Kingdom). Interleukin-6,
tumor necrosis factor (TNF)-a, adiponectin, leptin, and
resistin were measured in serum, and E-selectin was
measured in plasma, all with DuoSet ELISA development
kits from R&D Systems (Abingdon, United Kingdom).
Wire myography. One section of the gluteal fat biopsy
was placed in chilled physiological saline solution (composi-
tion in mmol/l: sodium chloride 118, potassium chloride 3.4,
magnesium sulphate 1.2, calcium chloride 1, sodium bicar-
bonate 25, glucose 11, potassium orthophosphate 1.2) and
oxygenated. The dissection dish was placed on ice during
microdissection to preserve the integrity of the tissue, whereas
arterial segments 250 to 350 mm in diameter were harvested,
1 segment with PVAT intact, and the adjacent segment
devoid of PVAT. Both segments came from the same artery.
Endothelium denuded vessels were mounted on 40-mm
wires and studied with wire myography (Danish MyoTech,
Aarhus, Denmark).
The mounted vessel segments were oxygenated and
maintained at a temperature of 37C before vessel diameter
and wall tension was normalized as previously described
(7,15). Vessels were challenged with a 60-mmol/l high-
potassium physiological saline solution to establish viability
and baseline constriction.
Each vessel segment was stimulated with cumulative
doses of norepinephrine (Sigma-Aldrich, Dorset, United
Kingdom) at the following doses: 109; 108; 3  108;
107; 3  107; 5  107; 106; 2  106; 3  106; 5 
106; 105; 2  105; and 3  105 mol/l. Contractile
responses to norepinephrine are presented as a percentage of
high-potassium physiological saline solution constriction,
consistent with published data (7,16–18).
Pharmacological assessment. Pharmacological protocols
were applied to study the effect of PVAT on adjacent small
arteries. In each case 2 segments of the same artery were
prepared with and without PVAT attached as previously
described (7).
The role of oxidative stress was evaluated by incubation of
samples from pre-operative patients with superoxide dis-
mutase and catalase (superoxide dismutase, Sigma-Aldrich,
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130100-m/ml incubation period 45 min; and catalase, Sigma-
Aldrich, 100-m/ml incubation period 45 min; n ¼ 4).
Further protocols assessed the contribution of NO and
adiponectin to PVAT function in samples taken from
patients after weight loss. Arteries with PVAT were incu-
bated with blocking peptide for adiponectin receptor 1
(AdipoR1) (5 mg/ml, 1.6  104 mol/l, Enzo Life Sciences;
45 min; n ¼ 7) and N5-[imino(methylamino)methyl]-L-
ornithine, citrate (5  105 mol/l, Sigma; 45 min; n ¼ 4).
NO assay. Five paired pre-operative and post-operative
frozen PVAT samples were homogenized by suspending
the tissue in 400 ml of lysis buffer (50 mmol/l Tris base,
150 mmol/l sodium chloride, 2 mmol/l ethylenediaminete-
traacetic acid, 2 mmol/l ethyleneglycoltetraacetic acid, 40
mmol/l b-glycerophosphate, 50 mmol/l sodium ﬂuoride, 10
mmol/l sodium pyrophosphate, 10% glycerol, 1% Triton X-
100 [pH 7.4]) and protease inhibitor (Complete Mini
EDTA-Free; Roche Diagnostics, Basel, Switzerland) on ice
and using a Dounce (glass/glass) tissue grinder set (Sigma-
Aldrich). Upon complete homogenization, the solution was
incubated at 4C for 10 min, then centrifuged for 10 min at
16,000 g. The resulting supernatant was then removed for
application of the assay.
Total nitrate/nitrite concentration was measured with
a NO colorimetric assay kit according to the instructions of
the manufacturer (Abcam).Figure 1
Effect of PVAT on Small Artery Tone Before and
After Surgery
(A) In pre-surgery patients, the presence of perivascular adipose tissue (PVAT) did
not affect vessel contractility as compared with skeletonized segments of the
same vessel (n ¼ 20, p ¼ 0.95). (B) In post-surgery patients, the presence of
PVAT had a signiﬁcant anticontractile effect on the small artery contractility
(n ¼ 15, *p < 0.01). KPSS ¼ high-potassium physiological saline; Log [NE] (M) ¼
log of the molar concentration of norepinephrine.Immunohistochemistry. MACROPHAGE MARKERS AND TNF-a.
Immediately after dissection, tissue from each gluteal biopsy
consisting of skin and subcutaneous fat was placed in 4%
paraformaldehyde in phosphate buffered saline for 24 h and
subsequently processed to parafﬁn wax blocks. Consecutive 5-
mm sections were de-waxed, rehydrated, and immunostained
for 2 macrophage markersdCD68 [KP1] (Dako, Glostrup,
Denmark; dilution 1:100), and CD68 [PGM1] (Biocare
Medical, Concord, California; dilution 1:100)dand the pro-
inﬂammatory cytokine TNF-a (Abcam; dilution 1: 100).
Antigen retrieval was performed, followed by blocking of
endogenous peroxidase and nonspeciﬁc protein binding with
Dako blocking solutions. Tissue sections were incubated with
primary antibodies for 18 h, followed by anti-rabbit/anti-
mouse EnVision-HRP (Dako) and ﬁnally by Vector SG
chromogen kit (Vector Laboratories, Burlingame, California),
used to disclose the presence of the macrophages and TNF-a.
Color images were captured with a Go-3 QImaging camera
(QImaging Corporation, Vancouver, Canada) mounted onFigure 2
Pharmacological Protocols on PVAT Pre-Surgery and
Post-Surgery
(A) Blocking peptide for polyclonal antibody to adiponectin receptor 1 increases
vessel contractility to norepinephrine (n ¼ 7, p <0.0001). (B) Incubation with
superoxide dismutase (SOD) and catalase rescues the PVAT anticontractile effect
in samples taken from pre-surgery patients (n ¼ 7, p < 0.001). (C) Post-surgery,
inhibition of nitric oxide synthase by incubation with N5-[imino(methylamino)
methyl]-L-ornithine, citrate (L-NMMA) leads to increased contractility of vessel
segments with intact PVAT (n ¼ 4, *p < 0.001). Abbreviations as in Figure 1.
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131a Leitz Diaplan microscope (Leica, Wetzlar, Germany). Cells
stained with macrophage markers present in adipose tissue
were counted, and the results were expressed as cells/mm2.
For assessment of TNF-a, quantitative analysis of immu-
nostaining was obtained, converting color images to greyscale
and with a macro subroutine in an ImagePro version 6.2
image analysis program (MediaCybernetics United Kingdom,
Marlow, United Kingdom). The extent of staining was
expressed as a percentage of the entire area photographed.
Adipocyte size was quantiﬁed on microphotographs obtained
on Zeiss Axio Imager M2 microscope equipped with Axio-
Cam camera and AxioVision Rel. 4.8 program by free-hand
tracing the margins of 100 consecutive cells (on average)/case
to avoid selection bias (total: 3,000 cells).
Immunohistochemistry for AdipoR1. Five mm deparafﬁ-
nized formalin-ﬁxed tissue sections were microwaved in
citrate buffer pH 6.0, treated with 0.3% hydrogen peroxide,
blocked with Protein Block (Dako), and incubated with 1 of
the anti-AdipoR1 antibodies, goat polyclonal to AdipoR1
(Abcam), or a rabbit monoclonal to AdipoR1 (Epitomics,
Burlingame, California), followed by anti-rabbit/anti-mouse
EnVision-HRP (Dako) and Vector SG chromogen kit
(Vector Laboratories). The results of immunostaining were
compared, and the monoclonal rabbit antibody was selected
for further use. Slides were examined and images captured
on a Zeiss Axio Imager M2 microscope.Figure 3 Subcutaneous Adipose Tissue Before and After Surgery
Inﬂammatory inﬁltrates composed mostly of macrophages were present in wreath-like arr
(CD68 (KP1) (C) allowed for performing cell counts. There was a signiﬁcant reduction in
4.1  0.7, *p < 0.01) (D). Scale bar ¼ 20 mm.Statistical analysis. The statistical presentation includes
paired and unpaired tests. In the case of ordinal tests, medians
and quartiles are used, and for parametric tests mean SD is
used. Cumulative concentration-response curves were con-
structed with data obtained by wire myography and analyzed
with a 2-way analysis of variance and a Bonferroni post hoc
test for each dose. A p value of <0.05 was considered
statistically signiﬁcant. Analyses were performed with the
GraphPad Prism 5 software (GraphPad, La Jolla, California).Results
Study design and participants. Six months after surgery
and weight loss, the patients had a signiﬁcantly lower waist
circumference (n ¼ 15; p < 0.0001), BMI (p < 0.0001), and
systolic blood pressure (p ¼ 0.0025) (Table 1).
Post-operatively, there was a signiﬁcant reduction in
insulin (p ¼ 0.0042), fasting glucose (p ¼ 0.0312), and
hemoglobin A1c (p < 0.0071) and an improvement in
pancreatic beta-cell function (homeostatic model assess-
ment of beta-cell function; p < 0.01) and insulin resis-
tance (homeostasis model assessment of insulin resistance;
p ¼ 0.0023). After surgery serum levels of adiponectin
increased signiﬁcantly (p ¼ 0.0197), and leptin decreased
(p ¼ 0.0014), but resistin levels did not change signiﬁ-
cantly (p ¼ 0.0796).angements (A), in groups (B), or were scattered. Staining for macrophage marker
the number of CD-68 staining macrophages post-surgery (n ¼ 14, 7.3  1.1 vs.
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132Weight-loss surgery restores PVAT anticontractile
function. In severely obese patients before surgery and
weight-loss, PVAT did not signiﬁcantly alter the
norepinephrine-induced contractility of the small arteries in
comparison with skeletonized segments of the same vessels
(n ¼ 15, p ¼ 0.96) (Fig. 1A).
In samples taken from patients 6 months after surgery and
weight loss, PVAT had a signiﬁcant anticontractile effect on
vessels when compared with vessels without PVAT (n ¼ 15,
p < 0.01) (Fig. 1B). The vessels with intact PVAT after
surgery had a very similar response to cumulative doses of
norepinephrine as the PVAT-intact vessels harvested from
healthy lean volunteers (p ¼ 0.52, n ¼ 7) (Fig. 1B). The
maximal degree of constriction is lower in PVAT-intact
vessels in healthy and post-surgery samples as compared
with skeletonized vessels, but the degree of constriction of
skeletonized vessels to norepinephrine is similar in segments
from pre- and post-surgery (Online Fig. 1).
Anticontractile property of PVAT after weight loss is
abolished by adiponectin blockade. Samples taken from
patients 6 months after surgery were incubated with blocking
peptide for AdipoR1. This had no effect on segments without
PVAT, but in vessels with PVAT there was a signiﬁcant
increase in vessel contractility (p < 0.0001, n ¼ 7) (Fig. 2A).
Free radical scavengers can rescue PVAT anticontractile
function in obesity. In patients with severe obesity, the
presence of perivascular adipose tissue had no effect on vesselFigure 4 Assessment of TNF-a Staining and Adipocyte Size Pre- and
Immunostaining for tumor necrosis factor (TNF)-a showed that adipocytes themselves we
Note positive staining of microvessels in the pre-operative biopsy. There is a signiﬁcant r
versus post-surgery (1.41  0.34 vs. 0.68  0.09, *p < 0.05) (C). The average adipocyt
post-surgery (D). Scale bar ¼ 20 mm.contractility in comparison with vessel segments devoid of
PVAT. Incubation of the vessels with the free radical scav-
engers superoxide dismutase and catalase resulted in a shift in
the curve to resemble that of vessels with intact PVAT taken
from healthy individuals (p < 0.001, n ¼ 7) (Fig. 2B).
Increased NO bioavailability after surgery. There was a
signiﬁcant increase in NO in PVAT of severely obese
patients 6 months after surgery (1.016 vs. 1.196 nmol/ml,
p ¼ 0.029, n ¼ 5).
In post-surgery samples, de-endothelialized vessel seg-
ments were incubated with N5-[imino(methylamino)
methyl]-L-ornithine, citrate. The incubation had no effect
on vessels without PVAT, but in vessels with PVAT, there
was a signiﬁcant increase in contractility to cumulative doses
of norepinephrine (p < 0.001, n ¼ 4) (Fig. 2C).
ReducedPVATinﬂammation, adipocyte size, andAdipoR1
after bariatric surgery. The perivascular adipose tissue was
stained, to quantify the inﬂammation, for both CD68
staining macrophages (Fig. 3) and the cytokine TNF-
a (Figs. 4A to 4C).
There was a signiﬁcant reduction in the CD68 [KP1]
staining macrophage numbers after surgery (7.3  1.1 vs.
4.1  0.7, p ¼ 0.0067, n ¼14) (Figs. 4C and 4D), but the
change in CD68 [PGM1] staining was not statistically
changed. There was a signiﬁcant reduction in the percentage
of adipose tissue area staining for TNF-a (1.41  0.34 vs.
0.68  0.09, p < 0.05) (Figs. 4A to 4C) after surgery.Post-Surgery
re positive for this cytokine, to a higher extent pre-surgery (A) than post-surgery (B).
eduction in the percentage of adipose tissue area that stains for TNF-a pre-surgery
e area was 7,672  369.6 mm2 pre-surgery and 3,955  207.5 mm2 (*p < 0.0001)
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133The average adipocyte area was 7,672  369.6 mm2 pre-
surgery and 3,955  207.5 mm2 (p < 0.0001) post-surgery
(Fig. 4D). The change in average adipocyte area correlated
with the change in BMI after surgery (R2 ¼ 0.356,
p ¼ 0.0243, n ¼ 14) (Online Fig. 2).
There was a signiﬁcant reduction in circulating markers of
inﬂammation including hsCRP (p < 0.001), interleukin-6
(p ¼ 0.013), monocyte chemoattractant protein-1 (283.1
vs. 258.3 pg/ml; p ¼ 0.013), and the adhesion molecule E-
selectin (12.7 vs. 7.47 ng/ml; p < 0.001). However, there
was no signiﬁcant change in circulating TNF-a levels
(p ¼ 0.519) (Table 1).Discussion
The present study investigated the effect of bariatric surgery on
the vasodilatory properties of PVAT. We designed the study
after our earlier observation that, in severely obese patients,
although there is an accumulationof adipose tissue, there is also
a paradoxical inhibition of the beneﬁcial PVAT vasodilation
(7). There are now 3 main ﬁndings presented here. First,
bariatric surgery reverses the obesity-induced damage to
PVAT anticontractile function. Second, the functional
recovery of the PVAT is independent of the endothelium.
Third, bariatric surgery restores the function of PVAT by
reducing adipose inﬂammation and increasing local adipo-
nectin and NO bioavailability (Figure 5). The observations
advance our understanding of the mechanisms by which
obesity disrupts the vasodilating function of adipose tissue and
how this pathology might be reversed by clinical intervention.
The cardiovascular complications of obesity are un-
doubtedly among the most pressing issues facing clinicians
today (19). To date, the most common recommended
intervention has been the encouragement of dietaryTable 1 Patient Demographic Data and Biomark
Healthy Pre
Age, yrs 51.0  11.5 53.
Waist, cm 92.0  11.6 140.9
BMI, kg/m2 25.40  2.68 51.5
Systolic BP, mm Hg 135.0  17.2 146.
hsCRP, mg/l 1.33  1.09 6.32
IL-6, pg/ml 2.070  0.811 2.83
TNF-a, pg/ml 4.83  1.75 35.1
Adiponectin, mg/l 2.190  0.633 1.84
Leptin, ng/ml 9.67  7.76 59.
Resistin, ng/ml 9.26  3.05 15.78
E-selectin, ng/ml 131.0  5.06 12.53
Insulin, mU/l 7.18  4.11 27.8
Glucose, mmol/l 5.080  0.377 6.82
HbA1C, % 5.740  0.689 7.
HOMA-B, % 90.2  26.9 243.
HOMA-IR, % 0.933  0.557 7.83
Values are mean  SD. The p values compare the matched baseline and p
BP ¼ blood pressure; BMI ¼ body mass index; HbA1C ¼ hemoglobin A
HOMA-IR ¼ homeostasis model assessment of insulin resistance; hsCRP
necrosis factor.modiﬁcation. Effective and sustained dieting does lead,
without doubt, to signiﬁcant weight loss, but unfortunately
the weight loss is not sustained (20). Furthermore, the
impact of dietary modiﬁcation on cardiovascular outcomes is
unclear (13,21). For patients with severe obesity, the most
effective method of achieving signiﬁcant and sustained
weight reduction is by weight-reducing surgery (14). In
addition, the weight loss after surgery also signiﬁcantly
correlates with improvements to blood pressure (22,23), left
ventricular mass (24), exercise capacity (25), and glucose
metabolism (26). Changes to weight in patients are associ-
ated with profound modulation of the cytokine and
inﬂammatory proﬁles of adipose tissue. In this regard, it is
now established that, in obese patients, adipose tissue
undergoes dual processes of hypoxia and inﬂammation,
leading to a reduction in the secretion of adipocytokines
such as adiponectin. The hypoxia is thought to be due to
adipocyte hypertrophy (27) twinned with reductions to
capillary density and angiogenic capacity (28). This results in
up-regulation of hypoxia inducible factor-1 and inﬂamma-
tory differentiation of macrophages, which subsequently
secrete TNF-a (29–31). Differentiated macrophages in
obesity also release superoxide anions, which further
contribute to local vascular dysfunction by diminishing
availability of NO (32).
The functional damage we observe in PVAT and its
recovery after bariatric surgery are entirely consistent with
this hypoxia/inﬂammation in fat hypothesis. Thus, in our
previous studies we observed adipocyte hypertrophy and
increased TNF staining in adipose tissue associated with loss
of PVAT vasodilatory function. We now show that, after
bariatric surgery, there is restoration of PVAT vasodilatory
capacity to a degree that is similar to that observed in healthy
non-obese participants. It is interesting to note that thiser Proﬁle
-Surgery Post-Surgery p Value
2  6.73 53.2  6.73
0  14.85 115.5  13.3 <0.0001
8  7.47 37.960  7.175 <0.0001
1  28.8 132.70  22.15 0.0025
1  2.444 2.747  2.282 0.0027
0  1.755 0.644  0.774 0.0052
4  40.30 27.14  37.30 0.12
5  0.699 2.410  0.828 0.011
9  17.7 24.91  10.42 0.0014
0  6.823 13.550  4.605 0.0796
0  5.581 8.753  3.374 0.0033
3  16.17 14.83  10.12 0.004
5  3.585 5.858  2.355 0.0312
0  2.119 6.330  1.603 0.0071
0  175.7 169.9  143.7 0.01
8  4.213 3.860  2.683 0.0023
ost-surgery values and were determined with paired t tests.
1c; HOMA-B ¼ homeostatic model assessment of beta-cell function;
¼ high-sensitivity C-reactive protein; IL ¼ interleukin; TNF ¼ tumor
Figure 5 Background and Conclusions
(A) In obesity there is an increase in perivascular adipose tissue (PVAT) levels of
inﬂammatory cells and cytokines as well as increase in levels of leptin. (B) We
conclude that, after bariatric surgery, there is an increase in adiponectin levels and
nitric oxide bioavailability in PVAT and reduction in tissue inﬂammation, which
contributes to restoration of PVAT anticontractile function. MCP ¼ monocyte
chemoattractant protein; TNF ¼ tumor necrosis factor.
Aghamohammadzadeh et al. JACC Vol. 62, No. 2, 2013
Bariatric Surgery, Obesity, and Perivascular Adipose July 9, 2013:128–35
134functional restoration of the PVAT occurs even though the
patients are still severely obese. The improvement in PVAT
function after surgery is associated with smaller adipocytes
(in the context of a dramatic weight loss), a reduction in
PVAT TNF, and increased local adipose tissue NO
bioavailability. Our ﬁndings are consistent with other studies
that have shown signiﬁcant reductions in macrophage
numbers as well as monocyte chemoattractant protein-1 and
hypoxia inducible factor-1a in the stromal vascular fraction
of white adipose tissue after bariatric surgery (33). Also,
importantly, we show that the functional vasodilatory
improvement in the subcutaneous fat is due to restitution of
PVAT-derived adiponectin and NO bioavailability.
The functional improvement ofPVATafter bariatric surgery
was independent of the vascular endothelium, because all
arteries in this study were denuded of endothelium. Alsonotably, there were no differences in constriction of arteries
devoid of fat to norepinephrine before and after surgery. Taken
together, these observations indicate that the improvement in
adipose-vascular coupling after surgery was due to improve-
ments in the vasodilating capacity of the PVAT rather than
changes to isolated arterial contractility or endothelial function.
Study limitations. There are a number of limitations to this
study that need to be considered in parallel with the ﬁndings.
We did not monitor the level of exercise performed by the
participants at baseline or after surgery, with respect to our
patient selection. At 6 months after surgery, the patients had
lost a signiﬁcant amount of weight and were presumably more
mobile. As such, we acknowledge that the improvement in
PVAT function might be as a consequence of increased levels
of mobility. Second, it would have been preferential to recruit
participants who were losing weight as part of a calorie-
controlled diet to compare changes to PVAT function due
to this intervention. This was not possible within the limita-
tions of our faculty, but we hope to perform this study in the
future. Similarly, a drawback of this study is that we were not
able to perform a 6-month follow-up biopsy on severely obese
patients who received no intervention. However, we assume
that there would have been no change in PVAT function over
this time. We have studied subcutaneous small arteries under
the assumption that all small arteries and the surrounding
PVAT share similar properties. A separate consideration is
that we have detected changes only to subcutaneous gluteal
PVAT after surgery.We did not study the function of PVAT
from other anatomical sites (i.e., mesenteric or skeletal). As
such, we acknowledge that changes to subcutaneous vascular
function might not be reﬂected in other vascular territories,
but previous studies have shown similar remodeling proﬁles of
human cerebral and mesenteric arteries to those seen in
arteries taken from gluteal subcutaneous biopsies. Finally, it
should be noted that norepinephrine was the only contractile
agent used. We acknowledge that it would have been prefer-
able to study a variety of vasoconstrictors. However, it should
be noted that studies from other groups have shown that
PVAT antagonizes contraction to U46619 (34), angiotensin
II (35,36), phenylephrine (35,37), and serotonin (35,36).
Conclusions
Despite these limitations, however, we believe that we present
convincing evidence that PVAT-induced vasodilation of small
arteries canbe fully restored after bariatric surgery. Furthermore,
this restoration of function is due to a reduction in inﬂammation
within the adipose tissue, which leads to increased adiponectin
secretion. The data offer an insight into 1 mechanism by which
bariatric surgery improves vascular function.We anticipate that
further work will harness this observation to improve thera-
peutic options for the severely obese patient.
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